Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;15(1):43-7.

Alterations of bone mineral metabolism of children with different cell lineage types of acute lymphoblastic leukaemia under chemotherapy

Alterations of bone mineral metabolism of children with different cell lineage types of acute lymphoblastic leukaemia under chemotherapy

A Tragiannidis et al. Hippokratia. 2011 Jan.

Abstract

Background: Children with haematological malignancies such as acute lymphoblastic leukaemia (ALL) may have alteration of bone mineral metabolism therefore increased risk for osteopenia and osteoporosis.

Patients and methods: The purpose of this study was to examine the alterations of bone mineral metabolism in two groups of children (n=42) according to immunophenotyping (B-cell type, T-cell type) both quantitative (bone mineral density z-scores) and qualitative (serum osteocalcin - OC and carboxyl-terminal telopeptide of human type I collagen - ICTP) during diagnosis (T=0), after the intensified chemotherapy period (T=0.5) and the consolidation period (T=1).

Results: According to our results 15 patients had osteopenia and 1 child developed osteoporosis at T=0.5 and 13 patients had osteopenia at T=1. Mean BMD z-score was significantly decreased in both groups during chemotherapy and especially statistically significant decline of T-cell type ALL group compared with B-cell type ALL patients. OC mean level remains in low levels for both groups reaching in plateau during chemotherapy and ICTP level was increased in T-cell type ALL group of patients compared with B-cell type in both periods of chemotherapy.

Conclusions: It seems that not only the combination of chemotherapeutic agents but also the cell lineage of ALL are important parameters of altering bone mineral metabolism.

Keywords: acute lymphoblastic leukemia; bone biochemical markers; bone mineral density; cell lineage; children.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Alterations of mean BMD z-score at different periods of chemotherapy for T-cell and B-cell ALL patients
Figure 2
Figure 2. Mean BMD z-score curve during chemotherapy
Figure 3
Figure 3. Mean ICTP at different periods of chemotherapy T-cell and B-cell ALL patients
Figure 4
Figure 4. Mean ICTP curve during chemotherapy
Figure 5
Figure 5. Mean OC at different periods of chemotherapy T-cell and B-cell ALL patients
Figure 6
Figure 6. Mean OC curve during chemotherapy

Similar articles

Cited by

References

    1. Haddy T, Mosher R, Reaman G. Osteoporosis in survivors of acute lymphoblastic leukemia. The Oncologist. 2001;6:278–285. - PubMed
    1. Haddy TB, Adde MA, McCalla J, Domanski MJ, Datiles M, 3rd, Meehan SC, et al. Late effects in long-term survivors of highgrade non-Hodgkins lymphomas. J Clin Oncol. 1998;16:2070–2079. - PubMed
    1. Kaste SC. Skeletal toxicities of treatment in childen with cancer. Pediatr Blood Cancer. 2008;50:469–473. - PubMed
    1. Mosher RB, McCarthy BJ. Late effects in survivors of bone tumors. J Pediatr Oncol Nurs. 1998;15:72–84. - PubMed
    1. Sala A, Barr RD. Osteopenia and cancer in children and adolescents. Cancer. 2007;109:1420–1431. - PubMed

LinkOut - more resources